A Study of Romiplostim for the Treatment of Refractory Transfusion-dependent NSAA

NCT06535685 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Aplastic Anemia

Interventions

DRUG: Romiplostim

Sponsor

Peking Union Medical College Hospital